Drug intelligence / Profile preview

kisspeptin-54

Development stage
Preclinical
Lead developer
University of Kansas Medical Center
Modality
Peptides
Administration
Intravenous
01

Overview

KP54 (kisspeptin-54), also known as metastin, is a 54-amino acid peptide derived from the proteolytic cleavage of the KISS1 metastasis suppressor protein. It is the primary endogenous ligand for the G protein-coupled receptor KISS1R (also known as GPR54). KP54 is primarily recognized for its potent ability to suppress the metastatic colonization of cancer cells, particularly in melanoma and breast cancer, without affecting the growth of the primary tumor. While its canonical mechanism involves the activation of KISS1R, research from the University of Kansas Medical Center suggests that KP54 and other KISS1-derived peptides may also suppress metastasis through KISS1R-independent pathways, involving the inhibition of cell motility and the upregulation of mitochondrial oxidative phosphorylation. Additionally, KP54 plays a critical role in the hypothalamic-pituitary-gonadal axis by stimulating the secretion of gonadotropin-releasing hormone (GnRH).

Other names
metastinKISS1 (68-121)
02

Targets

KISS1R (Kisspeptin receptor)

Beyond the preview

Go deeper on kisspeptin-54.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kisspeptin-54.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call